Nantahala Capital Management, LLC - Sep 30, 2024 SCHEDULE 13G Report for Aprea Therapeutics, Inc. Common stock, par value $0.001 per share (APRE)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
Aprea Therapeutics, Inc. Common stock, par value $0.001 per share
Symbol
APRE
Shares outstanding
5.64M shares
Disclosed Ownership
412K shares
Ownership
7.3%
Form type
SCHEDULE 13G
Date filed
11/14/2024, 04:53 PM
Date of event
Sep 30, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 7.3% 412K 0 412K /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer
Wilmot B. Harkey 7.3% 412K 0 412K /s/ Wilmot B. Harkey Wilmot B. Harkey
Daniel Mack 7.3% 412K 0 412K /s/ Daniel Mack Daniel Mack